Brandywine Rlty Tr Stock Price, News & Analysis

Brandywine Realty Trust (NYSE: BDN) reported its Q1 2022 results, with a net income of $5.9 million, or $0.03 per diluted share. Funds from Operations (FFO) totaled $60.3 million, also at $0.35 per diluted share. The occupancy rate of the core portfolio was 89.4%, with new and renewal leases signed covering 428,000 square feet. Notably, mark-to-market rents increased by 20.4% on an accrual basis. The company is maintaining its 2022 earnings guidance of $0.17 to $0.25 per share and FFO guidance of $1.37 to $1.45 per share.

Brandywine Realty Trust (NYSE: BDN) will participate in the Citi 2022 Global Property CEO Conference on March 8, 2022, at 4:15 p.m. ET for a 35-minute presentation. The event can be accessed via webcast. A replay will be available an hour after the presentation until April 8, 2022. Brandywine, a leading real estate investment trust, focuses on urban and transit-oriented properties across major markets, owning 168 properties totaling 23.1 million square feet.

Brandywine Realty Trust (NYSE: BDN) will present at the Citi 2022 Global Property CEO Conference on March 8, 2022, at 4:15 p.m. ET, for approximately 35 minutes. The presentation will be available via live webcast, and a replay will be accessible one hour after the event, expiring on April 8, 2022. As of December 31, 2021, Brandywine Realty Trust operates 168 properties totaling 23.1 million square feet across key markets, focusing on urban and transit-oriented developments.

Brandywine Realty Trust (NYSE: BDN) announced a quarterly cash dividend of $0.19 per common share, payable on April 20, 2022. This is equivalent to an annual rate of $0.76 per share. The record date for this dividend is April 6, 2022. The company is set to release its first quarter earnings on April 20, 2022, followed by a conference call on April 21, 2022, at 9:00 a.m. Eastern. Brandywine Realty Trust operates in key U.S. markets, focusing on leasing and managing a portfolio of 168 properties totaling 23.1 million square feet.

Brandywine Realty Trust (NYSE:BDN) reported its financial results for the year ending December 31, 2021, showcasing a net income of $4.5 million, or $0.03 per diluted share, compared to $18.9 million in Q4 2020. Funds from Operations (FFO) stood at $60.4 million, or $0.35 per diluted share. The company achieved significant milestones, including a 10.3% growth in cash rent and a 16.2% growth in accrual rent for 2021. The occupancy rate of their core portfolio reached 91.3%, while new leases signed totaled 468,000 square feet in Q4. Guidance for 2022 projects FFO between $1.37 to $1.45 per diluted share.

Brandywine Realty Trust (NYSE: BDN) has announced the tax characteristics of its 2021 distributions, reported on Form 1099-DIV. The total gross distribution per share is $0.760000, with taxable ordinary dividends accounting for 83.9% of the total. Four dividend payments were made throughout 2021, each at $0.190000. Shareholders are advised to consult tax advisors regarding the specific treatment of these dividends, as the distributions primarily consist of ordinary dividends with minimal capital gains. A detailed tax report is available on the company's website.

Brandywine Realty Trust (NYSE:BDN) has declared a quarterly cash dividend of $0.19 per common share, payable on January 19, 2022, to shareholders of record by January 5, 2022. This dividend equates to an annual rate of $0.76 per share. The company is also set to hold its fourth quarter 2021 earnings conference call on February 3, 2022, at 9:00 a.m. Eastern. Brandywine focuses on urban, town center, and transit-oriented real estate, managing a portfolio of 172 properties totaling 24.2 million square feet as of September 30, 2021.

Brandywine Realty Trust (NYSE: BDN) announced that B.Labs at Cira Centre has achieved 50% leasing, attracting notable life science firms including BriaCell and Ceptur Therapeutics. Set to open in January 2022, B.Labs will offer high-quality research space, state-of-the-art technology, and specialized services, further solidifying Philadelphia as a premier life science hub. The facility is part of a master-planned $3.5B Schuylkill Yards community, emphasizing urban connectivity and wellness. Brandywine's Life Science platform encompasses over 3 million square feet of lab and research space, with expansion plans in Austin and Metro D.C.